FOXO1 and breast cancer: The PI3K/Akt signaling pathway primarily functions through phosphorylation activation of PI3K and AKT, with AKT1 shown to interact with TRIB3, inhibiting FOXO1 degradation and promoting SOX2 transcription to enhance BC cell stemness (Yu et al., 2019).